X

Logout?

You must be logged in to place an order. Are you sure you want to logout?

Logout
X

Delete Account

Are you sure you want to delete this account

Delete
X

Are you a current Dormer customer? Sign up for Online Access

Are you a new customer? Sign Up for a Dormer Account

Need Help

Need Help? Contact us or visit the How-To Videos here.

X

Request Received

Please check your Email to verify your request and follow the instructions to create a new password.

Continue
Go Back

2026/02: CAD-1000 Cutaneous Adverse Drug Reaction Series is revised to 28 haptens.
- I-010A, C-043, H-029 deleted from series
- CAD-29, CAD-30 & CAD-31 deleted from the series
- CAD-13: L-009 replaces C-043 (previously CAD-30)
- CAD-25: C-053 replaces H-029 (previously CAD-31)

Product ID:CAD-1000

Cutaneous Adverse Drug Reaction Series

Series:
  • CAD-1000
Composition:
Series NoArticle Description Conc(%)/Veh
CAD-1C-054 Cefixime trihydrate 10.0 pet
CAD-2A-030 Amoxicillin trihydrate 10.0 pet
CAD-3D-058 Dicloxacillin sodium salt hydrate 10.0 pet
CAD-4C-040 Cefotaxim sodium salt 10.0 pet
CAD-5D-059 Doxycyclin monohydrate 10.0 pet
CAD-6C-055 Cefpodoxime proxetil 10.0 pet
CAD-7E-024 Erythromycin base 10.0 pet
CAD-8S-012 Spiramycin base 10.0 pet
CAD-9C-041 Clarithromycin 10.0 pet
CAD-10P-040 Potassium clavulanate 10.0 pet
CAD-11C-042 Cotrimoxazole 10.0 pet
CAD-12N-007 Norfloxacine 10.0 pet
CAD-13L-009 Lamotrigine 10.0 pet
CAD-14C-044 Carbamazepine 1.0 pet
CAD-15H-027 Hydantoin 10.0 pet
CAD-16D-060 Diltiazem hydrochloride 10.0 pet
CAD-17C-045 Captopril 5.0 pet
CAD-18A-031 Acetylsalicylic acid 10.0 pet
CAD-19D-061B Diclofenac Sodium Salt 5.0 pet
CAD-20K-002B Ketoprofen 1.0 pet
CAD-21P-033 Piroxicam 1.0 pet
CAD-22A-032 Acetaminophen 10.0 pet
CAD-23A-033 Acyclovir 10.0 pet
CAD-24H-028 Hydroxyzine hydrochloride 1.0 pet
CAD-25C-053 Cefuroxime sodium 10.0 pet
CAD-26C-046 Clindamycin phosphate 10.0 pet
CAD-27C-047 Cefradine 10.0 pet
CAD-28C-048 Cefalexin 10.0 pet
Login to Order

Uses

The Cutaneous Adverse Drug Reaction Series (CAD-1000) contains chemicals and substances present in pharmaceutical products such as antibiotics, NSAID

Resources

Changes

2026/02: CAD-1000 Cutaneous Adverse Drug Reaction Series is revised to 28 haptens.
- I-010A, C-043, H-029 deleted from series
- CAD-29, CAD-30 & CAD-31 deleted from the series
- CAD-13: L-009 replaces C-043 (previously CAD-30)
- CAD-25: C-053 replaces H-029 (previously CAD-31)
2024/08: CAD-25/H-029 Hydrochlorothiazide is discontinued.
2025/04: CAD-13/C-043 Ciprofloxacine hydrochloride is discontinued.